Live Breaking News & Updates on Gujralt olverembatinib

Stay updated with breaking news from Gujralt olverembatinib. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

China's First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into the 2022 National Reimbursement Drug List

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

Australia , United-states , Hong-kong , Netherlands , Philadelphia , Pennsylvania , Suzhou , Jiangsu , China , Rockville , Western-australia , Holland

Ascentage Pharma Announces Preclinical Data Demonstrating Olverembatinib's Therapeutic Potential in Treating COVID-19 Published in EMBO Molecular Medicine

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

China , Australia , Hong-kong , Netherlands , Rockville , Western-australia , Suzhou , Jiangsu , Holland , Ascentage-pharma , Dajun-yang , Gujralt-olverembatinib